SCHEMBL2557716

SCHEMBL2557716

COC(=O)c1ccc(O[C@H](C)CCC2CCN(C(=O)OC(C)(C)C)CC2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.46
RBBP4 Q09028 1/20 0.46
SUZ12 Q15022 1/20 0.46
EZH2 Q15910 1/20 0.46
AEBP2 Q6ZN18 1/20 0.46
GPR119 Q8TDV5 10/20 0.45
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
YAP1 P46937 2/20 0.42
PIK3CA P42336 1/20 0.42
PRKDC P78527 1/20 0.42
TGFBR1 P36897 1/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
STS P08842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2560698 0.90 GPR119 (0.46) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL26636540 0.85 GPR119 (0.47) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL26637294 0.85 GPR119 (0.47) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL26635583 0.85 GPR119 (0.47) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL26636545 0.85 GPR119 (0.47) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL26635590 0.85 GPR119 (0.47) GPR119ALDH1A1KDM4EPKMYAP1
SCHEMBL1295322 0.84 GPR119 (0.61) GPR119
SCHEMBL1833006 0.83 GPR119 (0.44) GPR119ALDH1A1KDM4EPKMNPC1
SCHEMBL1296099 0.81 EED (0.48) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL1847797 0.78 GPR119 (0.69) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011128394-A1 3-SUBSTITUTED 5-(PYRROLIDINE-1-CARBONYL) PYRROLIDINE AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2011-10-20 WO disclosed